PIA
ALDR

Piedmont Investment Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

Piedmont Investment Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,012
Closed -$16K – 2797
2018
Q2 		$16K Buy
+1,012
New +$15.4K ﹤0.01% 1668

Other funds holding ALDR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Piedmont Investment Advisors's ALDR Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Alder Biopharmaceuticals (ALDR) in Q3 2018, closing a stake of 1,012 shares — an estimated $16K sold.

Piedmont Investment Advisors first reported a position in ALDR in Q2 2018 and held it in 1 quarter. The position peaked at $16K in Q2 2018. 128 funds tracked by Wall St. Rank hold ALDR as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Alder Biopharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 1,012 Alder Biopharmaceuticals shares in Q3 2018, an estimated $16K.
  • Piedmont Investment Advisors first reported a position in Alder Biopharmaceuticals in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Alder Biopharmaceuticals position peaked at $16K in Q2 2018.
  • 128 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.